CG WG Call Notes leading to 2012 September WGM

August 21, 2012 -- Weekly call

Agenda

• Review the currently balloted GTR and discuss potential ballot comments
• Prepare the Baltimore WGM

Attendees

• Amnon Shabo; IBM
• Mollie Ullman-Cullere; Dana Farber
• Grant Wood; Intermountain Healthcare

August 14, 2012 -- Weekly call

Agenda

• Review the current status of the Family History US Implementation Guide

Attendees

• Amnon Shabo; IBM
• Mollie Ullman-Cullere; Dana Farber
• Scott Bolte; GE Healthcare
• Grant Wood; Intermountain Healthcare

Draft Minutes

• Reviewed the latest draft of the Family History US Implementation Guide
• Discussed family history requirements in Meaningful Use Stage 3
• Discussed options to include genetic and risk assessment data
• Decided to have two parts:
  • Part 1 - basic guidance
  • Part 2 - advanced guidance for genetic and risk data
• Grant Wood will facilitate the preparation of the US guide to the next ballot cycle

June 26, 2012 -- Weekly call

Agenda

• Review the current status of the Family History US Implementation Guide

Attendees

• Amnon Shabo; IBM
• Mollie Ullman-Cullere; Dana Farber

Web Meeting link

http://www.ibm.com/collaboration/meeting/join?id=1136358 (no password needed)

June 19, 2012 -- Weekly call

Agenda

• Discuss and approve Vancouver WGM minutes (http://wiki.hl7.org/index.php?title=CG_Working_Group_Meeting_Minutes)
• Omics DAM ballot reconciliation

Attendees

• Amnon Shabo; IBM
• Mollie Ullman-Cullere; Dana Farber
• Joyce Hernandez; Merck
• Don Rule; Transnational Software
• Vojtech Huser; NIH
• Katherine Olson;
• Scott Bolte; GE Healthcare
• Daryl Thomas; Life Technologies

Draft Minutes

• Vancouver minutes approved - none objected, two abstained
• Discussed a few of the Omics DAM ballot comments and voted (see reconciliation spreadsheet for details); will continue next week if time permits

June 12, 2012 -- Weekly call

Agenda

• Notification of Intent to Ballot Deadline -- Sunday, June 24
• Vancouver WGM minutes

Attendees

• Amnon Shabo; IBM
• Mollie Ullman-Cullere; Dana Farber
• Joyce Hernandez; Merck
• Scott Bolte; GE Healthcare
• Don Rule; Transnational Software

Draft Minutes

• Went through the list of ballot documents under Clinical Genomics
• Discussed whether the US Implementation Guide of the Pedigree spec should be balloted under Pedigree R2 or under the withdrawn canonical Pedigree project
• Since the canonical ballot document has in its title "Implementation Guide" and "US Realm", it seems more suitable than the Pedigree R2 document
• Decided to approach HL7 Hq. to take the word "canonical" out of the title and ballot the US IG under this ballot document
• GTR will be balloted, following the discussion and decision taken in Vancouver WGM, providing we can get the LOINC codes for the sections
• The Clinical Genomics DAM will not be balloted
• The Clinical Sequencing DAM should be balloted but is not listed, so will approach HL7 Hq. to resolve it
• No new v2 ballots
• Agenda for next calls:
  • Next week - the Clinical Genomics DAM; and also - discuss and approve the Vancouver minutes (please review them on the wiki
  • June 26 - discuss the US Family History Implementation Guide
  • July 10 - discuss the Clinical Sequencing ballot

May 29, 2012 -- Weekly call

Agenda

• Reports on Vancouver WGM

Attendees

• Amnon Shabo; IBM
• Joyce Hernandex; Merck
• Daryl Thomas; Life Technologies
• Scott Bolte; GE Healthcare
• Mukesh Sharma; Washington University
• Don Rule; Translational Software

Draft Minutes

• Decided to withdraw our project on Gene Expression Domain Analysis Model
• Discussed the option to develop a Pedigree FHIR Resource
• Reported on dicussions we had in Vancouver
• Discussed the changes proposed to DAM modeling in general and how it might affect our omics DAM modeling effort